冠状动脉CT血管成像的中心核心实验室判读与站点判读:PROMISE试验中的一致性与心血管事件关联
在PROMISE试验中,193个北美站点与中心核心实验室对4347例稳定胸痛患者的冠状动脉CT血管成像进行判读,16%的判读不一致,多为站点判读有显著CAD而核心实验室判读无;核心实验室判读的显著CAD患者数减少41%;中位随访25个月,核心实验室与站点判读对未来心肌梗死或心血管死亡的C统计量分别为0.61和0.63。
要点
- 核心实验室与站点判读显著CAD的不一致率为16%(683/4347),其中80%(544/683)为站点判读有而核心实验室判读无。
- 核心实验室判读的显著CAD患者比例较站点判读降低41%(14% vs 23%,P < .001)。
- 核心实验室与站点判读对未来心肌梗死或心血管死亡的C统计量分别为0.61和0.63。
核心结论
- 与193个北美站点判读者相比,标准化核心实验室判读将显著CAD患者分类减少41%。
研究设计与样本
- PROMISE试验的子研究,纳入4347例稳定胸痛患者(51.8%女性,平均年龄60.4岁±8.2),由193个北美站点判读者和中心核心实验室判读者分别判读冠状动脉CT血管成像,核心实验室判读对临床数据、站点判读和结局设盲。
诊断标准与关键数值
- 显著CAD定义为狭窄程度大于或等于50%;心血管事件定义为心血管死亡或心肌梗死的复合终点;核心实验室与站点判读不一致率为16%(683/4347),其中80%(544/683)为站点判读有显著CAD而核心实验室判读无;核心实验室判读显著CAD比例14%(595/4347)vs 站点判读23%(1000/4347),核心实验室判读减少41%(P < .001);中位随访25个月,1.3%(57/4347)发生心肌梗死或心血管死亡;核心实验室判读C统计量0.61(95%CI:0.54,0.68),站点判读C统计量0.63(95%CI:0.56,0.70)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess concordance and relative prognostic utility between central core laboratory and local site interpretation for significant coronary artery disease (CAD) and cardiovascular events. Materials and Methods In the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial, readers at 193 North American sites interpreted coronary computed tomographic (CT) angiography as part of the clinical evaluation of stable chest pain. Readers at a central core laboratory also interpreted CT angiography blinded to clinical data, site interpretation, and outcomes. Significant CAD was defined as stenosis greater than or equal to 50%; cardiovascular events were defined as a composite of cardiovascular death or myocardial infarction. Results In 4347 patients (51.8% women; mean age ± standard deviation, 60.4 years ± 8.2), core laboratory and site interpretations were discordant in 16% (683 of 4347), most commonly because of a finding of significant CAD by site but not by core laboratory interpretation (80%, 544 of 683). Overall, core laboratory interpretation resulted in 41% fewer patients being reported as having significant CAD (14%, 595 of 4347 vs 23%, 1000 of 4347; P < .001). Over a median follow-up period of 25 months, 1.3% (57 of 4347) sustained myocardial infarction or cardiovascular death. The C statistic for future myocardial infarction or cardiovascular death was 0.61 (95% confidence interval [CI]: 0.54, 0.68) for the core laboratory and 0.63 (95% CI: 0.56, 0.70) for the sites. Conclusion Compared with interpretation by readers at 193 North American sites, standardized core laboratory interpretation classified 41% fewer patients as having significant CAD. © RSNA, 2017 Online supplemental material is available for this article. Clinical trial registration no. NCT01174550.
引用
- Lu MT, Meyersohn NM, Mayrhofer T, et al. Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial. Radiology. 2017. PMID: 29178815. doi:10.1148/radiol.2017172181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。